CureVac study shows COVID jab only 47% efficient
CureVac N.V. unveiled on Wednesday the intermediary results from their latest phase of the coronavirus vaccine trials that showed that their vaccine was only 47% efficient against the global virus.
A…
Harry T. Partner's Academy & fpmarkets
NOI SIAMO UN GRUPPO DI LAVORO PER QUESTO NON TI CHIEDIAMO SOLDI. CON NOI NON SARAI SOLO
